Skip to main content

Site notifications

AusPAR: Sidapvia

Australian Public Assessment Report
Device/Product Name
Sidapvia
Active ingredients
Dapagliflozin 10 mg and sitagliptin 100 mg
AusPAR Date
Published
Submission Number
PM-2023-00672-1-5
Submission Type
New fixed dose combination
Decision
Approved

Help us improve the Therapeutic Goods Administration site